{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:10:49Z","timestamp":1784056249918,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001503","name":"Indian Council of Agricultural Research","doi-asserted-by":"publisher","award":["ICAR LAL Bahadur Shastry Outstanding Young Scientist Award ProjectF.no 5-4\/2022-A.C(e.21930) and Advanced Research Project on Canines."],"award-info":[{"award-number":["ICAR LAL Bahadur Shastry Outstanding Young Scientist Award ProjectF.no 5-4\/2022-A.C(e.21930) and Advanced Research Project on Canines."]}],"id":[{"id":"10.13039\/501100001503","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12368-8","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:13:47Z","timestamp":1784009627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum TP53 autoantibodies as a non-invasive diagnostic biomarker for canine mammary tumours: comparative insights from human and experimental rat model"],"prefix":"10.1007","volume":"53","author":[{"given":"Pradeep","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owais","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshwar","family":"Khandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha Pratim","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabapathi","family":"Nagappan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. V.","family":"Purushotham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"key":"12368_CR1","first-page":"1","volume":"10","author":"World Health Organisation","year":"2021","unstructured":"World Health Organisation (2021) Cancer: key facts. Int J Public Health 10:1\u20135","journal-title":"Int J Public Health"},{"key":"12368_CR2","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.jcpa.2016.05.011","volume":"155","author":"K Gr\u00fcntzig","year":"2016","unstructured":"Gr\u00fcntzig K, Graf R, Boo G, Guscetti F, H\u00e4ssig M, Axhausen KW et al (2016) Swiss canine cancer registry 1955\u20132008: occurrence of common tumour diagnoses and influence of age, breed, body size, sex and neutering status. J Comp Pathol 155:156\u2013170","journal-title":"J Comp Pathol"},{"key":"12368_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1354\/vp.36-5-423","volume":"36","author":"SA Benjamin","year":"1999","unstructured":"Benjamin SA, Lee AC, Saunders WJ (1999) Classification and behavior of canine mammary epithelial neoplasms in beagles. Vet Pathol 36:423\u2013436","journal-title":"Vet Pathol"},{"key":"12368_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1095-1029","volume":"1","author":"J Bergh","year":"1995","unstructured":"Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L (1995) Complete sequencing of the p53 gene provides prognostic information in breast cancer. Nat Med 1:1029\u20131034","journal-title":"Nat Med"},{"key":"12368_CR5","first-page":"455","volume-title":"Small animal clinical oncology","author":"GR Rutteman","year":"2001","unstructured":"Rutteman GR, Withrow SJ, MacEwen EG (2001) Tumours of the mammary gland. In: Withrow SJ, MacEwen EG (eds) Small animal clinical oncology, 3rd edn. WB Saunders, Philadelphia, pp 455\u2013467","edition":"3"},{"key":"12368_CR6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1939-1676.1999.tb01456.x","volume":"13","author":"JC Graham","year":"1999","unstructured":"Graham JC, Myers RK (1999) Prognostic significance of angiogenesis in canine mammary tumours. J Vet Intern Med 13:416\u2013418","journal-title":"J Vet Intern Med"},{"key":"12368_CR7","first-page":"4855","volume":"54","author":"MS Greenblatt","year":"1994","unstructured":"Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutation in the p53 tumour suppressor gene. Cancer Res 54:4855\u20134878","journal-title":"Cancer Res"},{"key":"12368_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/351453a0","volume":"351","author":"AJ Levine","year":"1991","unstructured":"Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453\u2013456","journal-title":"Nature"},{"key":"12368_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1006010526813","volume":"50","author":"LL Chu","year":"1998","unstructured":"Chu LL, Rutteman GR, Kong JMC et al (1998) Genomic organisation of canine p53 gene and its status in mammary neoplasia. Breast Cancer Res Treat 50:11\u201325","journal-title":"Breast Cancer Res Treat"},{"key":"12368_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/jcb.10699","volume":"91","author":"A Eastman","year":"2004","unstructured":"Eastman A (2004) Cell cycle checkpoints and anticancer therapeutic strategies. J Cell Biochem 91:223\u2013231","journal-title":"J Cell Biochem"},{"key":"12368_CR11","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.2460\/ajvr.1992.53.11.2196","volume":"53","author":"EA Sartin","year":"1992","unstructured":"Sartin EA, Barnes S, Kwapien RP, Wolfe LG (1992) Estrogen and progesterone receptor status in canine mammary carcinomas. Am J Vet Res 53:2196\u20132200","journal-title":"Am J Vet Res"},{"key":"12368_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1023\/A:1006010526813","volume":"50","author":"LL Chu","year":"1998","unstructured":"Chu LL, Rutteman GR, Kong JMC, Ghahremani M, Yang F, van Garderen E et al (1998) Genomic organization and mutation status of canine p53 in mammary neoplasia. Breast Cancer Res Treat 50:11\u201325","journal-title":"Breast Cancer Res Treat"},{"key":"12368_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1354\/vp.36-5-423","volume":"36","author":"SA Benjamin","year":"1999","unstructured":"Benjamin SA, Lee AC, Saunders WJ (1999) Classification and behavior of canine mammary epithelial neoplasms. Vet Pathol 36:423\u2013436","journal-title":"Vet Pathol"},{"key":"12368_CR14","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8<1472::AID-CNCR15>3.0.CO;2-2","volume":"80","author":"Z Popov","year":"1997","unstructured":"Popov Z, Hoznek A, Colombel M, Bastuji-Garin S, Lefrere-Belda MA, Bellot J et al (1997) p53 overexpression and MIB-1 in bladder carcinoma. Cancer 80:1472\u20131481","journal-title":"Cancer"},{"key":"12368_CR15","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.2460\/ajvr.1995.56.09.1188","volume":"56","author":"I Donnay","year":"1995","unstructured":"Donnay I, Rauis J, Devleeschouwer N, Wouters-Ballman P, Leclercq G, Verstegen J (1995) Estrogen and progesterone receptors in normal and tumour canine mammary tissues. Am J Vet Res 56:1188\u20131194","journal-title":"Am J Vet Res"},{"key":"12368_CR16","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1939-1676.1999.tb01456.x","volume":"13","author":"JC Graham","year":"1999","unstructured":"23, Graham JC, Myers RK (1999) Angiogenesis in canine mammary tumours. J Vet Intern Med 13:416\u2013418","journal-title":"J Vet Intern Med"},{"key":"12368_CR17","first-page":"2583","volume":"61","author":"EM Tan","year":"2001","unstructured":"Tan EM, Zhang J (2001) Autoantibodies as reporters identifying aberrant cellular mechanisms in tumourigenesis. Cancer Res 61:2583\u20132590","journal-title":"Cancer Res"},{"key":"12368_CR18","doi-asserted-by":"publisher","first-page":"152735","DOI":"10.1016\/j.bbrc.2025.152735","volume":"787","author":"P Kumar","year":"2025","unstructured":"Kumar P, Saxena S, Shrivastava S, Kumar V, Khan O, Nagappan S, Chittalangia MS (2025) Cross-species insights into CEACAM1 autoantibodies as diagnostic biomarkers for mammary cancer. Biochem Biophys Res Commun 787:152735","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"12368_CR19","doi-asserted-by":"publisher","first-page":"13485","DOI":"10.1038\/s41598-019-49998-x","volume":"9","author":"SC Jena","year":"2019","unstructured":"Jena SC, Shrivastava S, Saxena S, Kumar N, Maiti SK, Mishra BP, Singh RK (2019) Surface plasmon resonance immunosensor for label-free detection of BIRC5 biomarker in spontaneously occurring canine mammary tumours. Sci Rep 9(1):13485","journal-title":"Sci Rep"},{"issue":"12","key":"12368_CR20","doi-asserted-by":"publisher","first-page":"e0208656","DOI":"10.1371\/journal.pone.0208656","volume":"13","author":"S Hussain","year":"2018","unstructured":"Hussain S, Saxena S, Shrivastava S, Mohanty AK, Kumar S, Singh RJ, Kumar A, Wani SA, Gandham RK, Kumar N, Sharma AK (2018) Gene expression profiling of spontaneously occurring canine mammary tumours: Insight into gene networks and pathways linked to cancer pathogenesis. PLoS ONE 13(12):e0208656","journal-title":"PLoS ONE"},{"issue":"4","key":"12368_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ijc.2910300404","volume":"30","author":"LV Crawford","year":"1982","unstructured":"Crawford LV, Pim DC, Bulbrook RD (1982) Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int J Cancer 30(4):403\u2013408","journal-title":"Int J Cancer"},{"key":"12368_CR22","first-page":"862","volume":"66","author":"V Goodell","year":"2006","unstructured":"Goodell V, Salazar LG, Urban N et al (2006) Antibody immunity to p53 is associated with improved survival in ovarian cancer. Cancer Res 66:862\u2013869","journal-title":"Cancer Res"},{"key":"12368_CR23","first-page":"3663","volume":"55","author":"R Lubin","year":"1995","unstructured":"Lubin R, Zalcman G, Bouchet L et al (1995) Serum p53 antibodies in patients with lung cancer. Cancer Res 55:3663\u20133667","journal-title":"Cancer Res"},{"issue":"11","key":"12368_CR24","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1292\/jvms.64.973","volume":"64","author":"N Kanaya","year":"2002","unstructured":"Kanaya N, Okuda M, Toyama N, Oikawa T, Inokuma H, Morimoto M, Hayashi T, Une S, Nakaichi M, Taura Y, Tsujimoto H (2002) Detection of the anti-P53 antibodies in dogs with tumours. J Vet Med Sci 64(11):973\u2013979","journal-title":"J Vet Med Sci"},{"key":"12368_CR25","doi-asserted-by":"publisher","first-page":"1455602","DOI":"10.3389\/fimmu.2024.1455602","volume":"15","author":"A Montero-Calle","year":"2024","unstructured":"Montero-Calle A, L\u00f3pez-Calleja AI, Barderas R (2024) Autoantibodies as diagnostic biomarkers in cancer. Front Immunol 15:1455602","journal-title":"Front Immunol"},{"key":"12368_CR26","first-page":"1010","volume":"149","author":"RT Fortner","year":"2021","unstructured":"Fortner RT, Damms-Machado A, Kaaks R (2021) Circulating p53 autoantibodies and cancer risk. Int J Cancer 149:1010\u20131020","journal-title":"Int J Cancer"},{"key":"12368_CR27","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1038\/s41467-021-24836-9","volume":"12","author":"BA Alsaihati","year":"2021","unstructured":"Alsaihati BA et al (2021) Canine tumour mutational burden and TP53 alterations. Nat Commun 12:6000","journal-title":"Nat Commun"},{"issue":"16","key":"12368_CR28","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1158\/1078-0432.CCR-04-0220","volume":"10","author":"TO Nielsen","year":"2004","unstructured":"Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10(16):5367\u20135374","journal-title":"Clin Cancer Res"},{"key":"12368_CR29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1177\/0300985810393258","volume":"48","author":"M Goldschmidt","year":"2011","unstructured":"Goldschmidt M, Pe\u00f1a L, Rasotto R, Zappulli V (2011) Classification and grading of canine mammary tumours. Vet Pathol 48:117\u2013131","journal-title":"Vet Pathol"},{"key":"12368_CR30","unstructured":"Meuten DJ (ed) (2020) Tumors in domestic animals. Wiley. Feb 26"},{"key":"12368_CR31","first-page":"199","volume":"102","author":"MM M\u00fcller","year":"2009","unstructured":"M\u00fcller MM, Herlyn M, Jansen B (2009) TP53 in cancer progression and immune modulation. Adv Cancer Res 102:199\u2013223","journal-title":"Adv Cancer Res"},{"key":"12368_CR32","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nbt0906-1065b","volume":"24","author":"C Khanna","year":"2006","unstructured":"Khanna C, Lindblad-Toh K, Vail D et al (2006) The dog as a model for cancer. Nat Biotechnol 24:1065\u20131066","journal-title":"Nat Biotechnol"},{"key":"12368_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12917-021-02901-1","volume":"17","author":"R S\u00e1nchez-C\u00e9spedes","year":"2021","unstructured":"S\u00e1nchez-C\u00e9spedes R, Fern\u00e1ndez-Mart\u00ednez MD, Raya AI, Pineda C, L\u00f3pez I, Mill\u00e1n Y (2021) VDR expression in canine mammary carcinoma. BMC Vet Res 17:1\u201314","journal-title":"BMC Vet Res"},{"key":"12368_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ccr.2007.10.001","volume":"12","author":"T Soussi","year":"2007","unstructured":"Soussi T, Wiman KG (2007) The p53 mutation paradigm. Cancer Cell 12:303\u2013312","journal-title":"Cancer Cell"},{"key":"12368_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","volume":"25","author":"PAJ Muller","year":"2014","unstructured":"Muller PAJ, Vousden KH (2014) Mutant p53: new functions and therapeutic opportunities. Cancer Cell 25:304\u2013317","journal-title":"Cancer Cell"},{"key":"12368_CR36","doi-asserted-by":"publisher","first-page":"e99255","DOI":"10.1371\/journal.pone.0099255","volume":"9","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhu Z, Liu Y, Jin J, Zhou J (2014) Diagnostic value of serum p53 antibody. PLoS ONE 9:e99255","journal-title":"PLoS ONE"},{"key":"12368_CR37","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.3390\/cancers13061440","volume":"13","author":"N Sobhani","year":"2021","unstructured":"Sobhani N, D\u2019Angelo A, Pittacolo M et al (2021) p53 antibody as a cancer biomarker. Cancers (Basel) 13:5098","journal-title":"Cancers (Basel)"},{"key":"12368_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4142\/jvs.2004.5.1.63","volume":"5","author":"CH Lee","year":"2004","unstructured":"Lee CH, Kim WH, Lim JH, Kim DY, Kweon OK (2004) Expression of p53, c-erbB-2, and Ki-67 in canine mammary carcinoma. J Vet Sci 5:63\u201370","journal-title":"J Vet Sci"},{"key":"12368_CR39","first-page":"471","volume":"54","author":"JC Oliveira-Filho","year":"2017","unstructured":"Oliveira-Filho JC, Kommers GD, Masuda EK et al (2017) Comparative analysis of canine mammary tumours with human breast cancer. Vet Pathol 54:471\u2013478","journal-title":"Vet Pathol"},{"key":"12368_CR40","first-page":"741","volume":"16","author":"AC Joerger","year":"2016","unstructured":"Joerger AC, Fersht AR (2016) The p53 pathway: origins and therapeutic approaches. Nat Rev Cancer 16:741\u2013752","journal-title":"Nat Rev Cancer"},{"key":"12368_CR41","first-page":"9448","volume":"46","author":"AC Joerger","year":"2018","unstructured":"Joerger AC, Rajagopalan S, Natan E, Veprintsev DB, Fersht AR (2018) Structural evolution of p53\u2013DNA binding. Nucleic Acids Res 46:9448\u20139460","journal-title":"Nucleic Acids Res"},{"key":"12368_CR42","first-page":"1777","volume":"60","author":"T Soussi","year":"2000","unstructured":"Soussi T (2000) p53 antibodies in cancer patients. Cancer Res 60:1777\u20131788","journal-title":"Cancer Res"},{"issue":"Suppl 8","key":"12368_CR43","first-page":"S1344","volume":"6","author":"R Kaaks","year":"2017","unstructured":"Kaaks R, Sookthai D, Fortner RT et al (2017) Anti-p53 antibodies and cancer risk. Transl Cancer Res 6(Suppl 8):S1344\u2013S1355","journal-title":"Transl Cancer Res"},{"key":"12368_CR44","first-page":"5120","volume":"9","author":"JA Koziol","year":"2003","unstructured":"Koziol JA, Zhang JY, Casiano CA et al (2003) Recursive partitioning for tumour marker selection. Clin Cancer Res 9:5120\u20135126","journal-title":"Clin Cancer Res"},{"key":"12368_CR45","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1021\/pr8002886","volume":"7","author":"J Qiu","year":"2008","unstructured":"Qiu J, Choi G, Li L et al (2008) Autoantibodies prior to breast cancer diagnosis. J Proteome Res 7:4013\u20134022","journal-title":"J Proteome Res"},{"key":"12368_CR46","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nm0795-701","volume":"1","author":"R Lubin","year":"1995","unstructured":"Lubin R, Zalcman G, Bouchet L et al (1995) Serum p53 antibodies as markers of lung cancer. Nat Med 1:701\u2013702","journal-title":"Nat Med"},{"key":"12368_CR47","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2741\/4593","volume":"23","author":"JY Zhang","year":"2018","unstructured":"Zhang JY, Tan EM (2018) Autoantibodies to tumour-associated antigens. Front Biosci 23:2097\u20132120","journal-title":"Front Biosci"},{"key":"12368_CR48","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1158\/1078-0432.CCR-16-1467","volume":"23","author":"W Yang","year":"2017","unstructured":"Yang W, Qiu J, Ye H et al (2017) Autoantibody signatures for early breast cancer detection. Clin Cancer Res 23:2681\u20132690","journal-title":"Clin Cancer Res"},{"key":"12368_CR49","first-page":"823559","volume":"12","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang H, Su L et al (2022) Pre-diagnostic serum p53 antibodies as biomarkers. Front Oncol 12:823559","journal-title":"Front Oncol"},{"key":"12368_CR50","first-page":"293","volume":"8","author":"MW McIntosh","year":"2010","unstructured":"McIntosh MW, Drescher CW, Karlan BY et al (2010) CA125 and autoantibody biomarkers in ovarian cancer. Cancer Biomark 8:293\u2013305","journal-title":"Cancer Biomark"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12368-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12368-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:03:17Z","timestamp":1784055797000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12368-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12368"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12368-8","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"17 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institute Animal Ethics Committee (IAEC) of the ICAR\u2013Indian Veterinary Research Institute (IVRI), Izatnagar, Bareilly, India (Approval Nos. F.26\u2009\u2212\u20091\/2015-16\/JD.R, dated: 28 February 2019; 26\u2009\u2212\u20091\/2023-24\/JD(R)\/IAEC, dated: 7 November 2023). All animal experiments were performed in accordance with the guidelines of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Government of India (2005 amendment), and in compliance with the ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines. Human serum samples were obtained from Keshlata Cancer Hospital, Bareilly, Uttar Pradesh following approval from the institutional ethics committee, with written informed consent obtained from all participants. All procedures involving human participants were conducted in accordance with the ethical standards of the institutional and\/or national research committee and with the 2013 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1156"}}